Here's something nobody warns you about when you're learning biology: cells lie about who they are. Not maliciously - more like a mid-career professional quietly pivoting from accounting to pottery. Researchers just caught smooth muscle cells doing exactly this inside human coronary arteries, and the implications for heart disease are wild.
A team led by Daniel Morales-Cano and colleagues at the University of Copenhagen decided to do something surprisingly rare in cardiovascular research: actually look at what's happening in human arteries at different stages of atherosclerosis, rather than just assuming mouse results translate over. Spoiler alert - they found some interesting differences.
When Muscle Cells Go Rogue
Smooth muscle cells are supposed to be the reliable contractors of your blood vessels. They contract, they relax, they keep blood flowing where it should go. But when atherosclerosis starts developing - that gradual plaque buildup that causes heart attacks - these cells apparently decide their current job isn't working out.
The research team examined 44 arterial segments from 38 individuals, spanning everything from healthy arteries to full-blown fibroatheromas (the fancy term for plaques with a mushy, lipid-filled core that can rupture and ruin your whole week). Using markers validated by single-cell RNA sequencing, they tracked different populations of mesenchymal cells - a category that includes smooth muscle cells and their various career-change outcomes.
Here's where it gets interesting: cells expressing lumican, a protein associated with fibroblasts (the cells that make scar tissue), only showed up in significant numbers at the fibroatheroma stage. And where did these fibroblast-like cells prefer to hang out? Right around the necrotic core - the dead, inflammatory center of dangerous plaques.
The Apoptosis Connection
The team found that these lumican-expressing cells accounted for 38-54% of all apoptotic (dying) cells in plaques where they could identify the cell type. That's a huge chunk of the death toll happening inside arterial plaques.
Think about it this way: smooth muscle cells transform into fibroblast-like cells, migrate toward the necrotic core, and then die there in large numbers. They're essentially participating in their own destruction - and potentially making the plaque more dangerous in the process, since dead cells contribute to that unstable, rupture-prone core.
Previous research using mouse models and human samples has shown that smooth muscle cells can adopt multiple alternative phenotypes during atherosclerosis [DOI: 10.1161/CIRCRESAHA.120.315853]. But this study provides the first detailed map of when and where these transitions happen during human coronary plaque progression.
The Osteoprotegerin Mystery
The researchers also tracked cells expressing osteoprotegerin, a protein involved in bone metabolism. These cells didn't cluster around the necrotic core like the lumican-expressing ones, but secreted osteoprotegerin was found bound to calcium deposits in plaques. Calcification in arteries is complicated - sometimes it stabilizes plaques, sometimes it makes them worse. The relationship between these osteoprotegerin-expressing cells and calcification needs more investigation.
Interestingly, neither mesenchymal cell subtype showed preferential co-localization with fibrotic areas. The fibroblast-like cells weren't actually doing much fibrosis, despite looking like fibroblasts. They were mostly just... dying near the necrotic core.
What This Means for Treatment
Current approaches to atherosclerosis mostly focus on lowering cholesterol and reducing inflammation. But if smooth muscle cell phenotype switching contributes significantly to necrotic core development - the thing that makes plaques dangerous - there might be therapeutic opportunities in preventing or redirecting that transformation.
Single-cell technologies have revolutionized our ability to understand these complex cellular ecosystems [DOI: 10.1038/s41591-022-02060-0]. Tools like mapb2.io can help visualize complex cellular relationships and phenotype transitions, making it easier to wrap your head around how these different cell populations interact.
The machine learning-assisted cell classification used in this study allowed the researchers to phenotype entire plaques at high microscopic resolution - something that would have been impossibly tedious just a decade ago. When you're trying to count and categorize thousands of cells across dozens of tissue sections, automation isn't just convenient; it's essential.
The Bottom Line
Your smooth muscle cells are more plastic than anyone expected. During atherosclerosis progression, some of them transform into fibroblast-like cells that accumulate around the most dangerous part of arterial plaques and die in significant numbers. This process becomes prominent at the fibroatheroma stage - exactly when plaques transition from stable nuisances to potential heart attack triggers.
The researchers conclude that targeting this phenotypic modulation could represent a new therapeutic avenue for stabilizing vulnerable plaques. Of course, turning that insight into an actual treatment will require years of additional research. But understanding the problem is step one.
Sometimes the most dangerous thing in your body isn't an invader from outside. It's your own cells deciding they'd rather be something else - and not handling the transition particularly well.
References
-
Morales-Cano D, Sharysh D, Albarrán-Juárez J, et al. Fibroblast-like cells accumulate late in human coronary atherosclerosis contributing to necrotic core formation. Cardiovascular Research. 2025. DOI: 10.1093/cvr/cvag002. PMID: 41553378
-
Wirka RC, Wagh D, Paik DT, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nature Medicine. 2019;25(8):1280-1289. DOI: 10.1038/s41591-019-0512-5
-
Alencar GF, Owsiany KM, Karneez S, et al. Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis. Circulation. 2020;142(21):2045-2059. DOI: 10.1161/CIRCULATIONAHA.120.046672
-
Pan H, Xue C, Auerbach BJ, et al. Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human. Circulation. 2020;142(21):2060-2075. DOI: 10.1161/CIRCRESAHA.120.315853
Disclaimer: This blog post is a simplified summary of published research for educational purposes. The accompanying illustration is artistic and does not depict actual model architectures, data, or experimental results. Always refer to the original paper for technical details.